Last updated: 2026-10-15 22:34:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Olema Pharmaceuticals, Inc. (OLMA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.86, with a market capitalization of $614.23M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.61 to $36.26. This page covers its latest market performance, valuation, price trends and company information.
$614.23M | |
$6.73 | |
$60.27 | |
$2.00 | |
$6.80 | |
369.28K | |
1.09M | |
-- | |
$36.26 | |
$6.61 | |
-- | |
-- |
Olema Pharmaceuticals, Inc. (OLMA) is trading at $6.87 in after-hours trading as of 2026-10-15 19:59:51, up 0.96% ($0.07) from the regular-session close of $6.80.
After-hours trading shows how investors are pricing OLMA after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Olema Pharmaceuticals, Inc. (OLMA) moved from $7.92 to $6.86, representing a decline of 13.35% ($1.06).
The stock traded between $6.61 and $8.29 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.27 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.9%
OLMA is currently trading at $6.86, placing it 0.9% of the way from its 52-week low of $6.61 to its 52-week high of $36.26. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 150 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Olema Pharmaceuticals, Inc. (OLMA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.